|Day Low/High||75.34 / 76.85|
|52 Wk Low/High||44.36 / 79.45|
I think Textron is a buy after the nearly-12% beating it took last week.
The market is a living, breathing organism that must be closely tracked -- else it will destroy your portfolio.
A trio of unheralded cycles are working even in this horrendous environment.
UnitedHealth, Humana and Aetna say they will keep parts of President Obama's health care law even if it does not survive the Supreme Court ruling later this month.
I believe this week's news-inspired breakout will carry Textron higher in the coming weeks.
Ingersoll Rand seems to be in the early phase of a breakout, and Textron could be setting up for a climb back upward.
With expiration upon us, I'm crawling into a hole to consider my plays for next week.
No one expects it to disappoint, and these two butterfly spreads could capture some upside.
Shares of the defense name attracted its heaviest upside volume in more than two years.
If traders can believe rumors of a United Technologies deal, then there's hope.